IceCure Medical/ICCM

$1.35

4.8%
-
1D1W1MYTD1YMAX

About IceCure Medical

Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.

Ticker

ICCM

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Eyal Shamir

Employees

71

Headquarters

Caesarea, Israel

IceCure Medical Metrics

BasicAdvanced
$57.16M
Market cap
-
P/E ratio
-$0.32
EPS
2.85
Beta
-
Dividend rate
$57.16M
2.8515
$1.57
$0.52
482.87K
3.664
3.076
-62.89%
-77.97%
-76.33%
17.703
4.7
4.7
4.67%
30.03%
-5.84%

What the Analysts think about IceCure Medical

Analyst Ratings

Majority rating from 4 analysts.
Buy

Price Targets

Average projection from 4 analysts.
146.67% upside
High $4.41
Low $2.90
$1.35
Current price
$3.33
Average price target

IceCure Medical Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-241.66% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$1.2M
300%
Net income
$-2.9M
-27.5%
Profit margin
-241.66%
-81.88%

IceCure Medical Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 7.14%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.08
-$0.08
-$0.09
-$0.07
-
Expected
-$0.09
-$0.09
-$0.09
-$0.07
-$0.08
Surprise
-14.29%
-7.69%
-3.33%
-7.14%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for IceCure Medical stock?

IceCure Medical (ICCM) has a market cap of $57.16M as of April 16, 2024.

What is the P/E ratio for IceCure Medical stock?

The price to earnings (P/E) ratio for IceCure Medical (ICCM) stock is 0 as of April 16, 2024.

Does IceCure Medical stock pay dividends?

No, IceCure Medical (ICCM) stock does not pay dividends to its shareholders as of April 16, 2024.

When is the next IceCure Medical dividend payment date?

IceCure Medical (ICCM) stock does not pay dividends to its shareholders.

What is the beta indicator for IceCure Medical?

IceCure Medical (ICCM) has a beta rating of 2.85. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the IceCure Medical stock price target?

The target price for IceCure Medical (ICCM) stock is $3.33, which is 146.67% above the current price of $1.35. This is an average based on projections from 4 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell IceCure Medical stock

Buy or sell IceCure Medical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing